-
1
-
-
0036176161
-
K/DOQI clinical practice guidelines for chronic kidney disease: Evaluation, classification, and stratification
-
National Kidney Foundation
-
National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis 2002;39:S1-266.
-
(2002)
Am J Kidney Dis
, vol.39
-
-
-
2
-
-
84897452221
-
Pro: Thresholds to define chronic kidney disease should not be age-dependent
-
Conte G, Minutolo R, De Nicola L. Pro: thresholds to define chronic kidney disease should not be age-dependent. Nephrol Dial Transplant 2014;29:770-4.
-
(2014)
Nephrol Dial Transplant
, vol.29
, pp. 770-774
-
-
Conte, G.1
Minutolo, R.2
De Nicola, L.3
-
3
-
-
84897461810
-
Con: Thresholds to define chronic kidney disease should not be age dependent
-
Glassock R. Con: thresholds to define chronic kidney disease should not be age dependent. Nephrol Dial Transplant 2014;29:774-9.
-
(2014)
Nephrol Dial Transplant
, vol.29
, pp. 774-779
-
-
Glassock, R.1
-
5
-
-
84874644599
-
KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease
-
Kidney Disease: Improving Global Outcomes (KDIGO) Work Group
-
Kidney Disease: Improving Global Outcomes (KDIGO) Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013;3:1-150.
-
(2013)
Kidney Int Suppl
, vol.3
, pp. 1-150
-
-
-
7
-
-
79955009821
-
Detection of chronic kidney disease with creatinine, cystatin C, and urinary albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality
-
Peralta CA, Shlipak MG, Judd S, Cushman M, McClellan W, Zakai NA, et al. Detection of chronic kidney disease with creatinine, cystatin C, and urinary albumin-to-creatinine ratio and association with progression to end-stage renal disease and mortality. JAMA 2011;305:1545-52.
-
(2011)
JAMA
, vol.305
, pp. 1545-1552
-
-
Peralta, C.A.1
Shlipak, M.G.2
Judd, S.3
Cushman, M.4
McClellan, W.5
Zakai, N.A.6
-
8
-
-
84875014115
-
Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes
-
Waheed S, Matsushita K, Astor BC, Hoogeveen RC, Ballantyne C, Coresh J. Combined association of creatinine, albuminuria, and cystatin C with all-cause mortality and cardiovascular and kidney outcomes. Clin J Am Soc Nephrol 2013;8:434-42.
-
(2013)
Clin J Am Soc Nephrol
, vol.8
, pp. 434-442
-
-
Waheed, S.1
Matsushita, K.2
Astor, B.C.3
Hoogeveen, R.C.4
Ballantyne, C.5
Coresh, J.6
-
9
-
-
84860786143
-
Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate
-
Matsushita K, Mahmoodi BK, Woodward M, Emberson JR, Jafar TH, Jee SH, et al. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012;307:1941-51.
-
(2012)
JAMA
, vol.307
, pp. 1941-1951
-
-
Matsushita, K.1
Mahmoodi, B.K.2
Woodward, M.3
Emberson, J.R.4
Jafar, T.H.5
Jee, S.H.6
-
10
-
-
84863984918
-
Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) study equation for estimated GFR
-
for the Alberta Kidney Disease Network
-
Matsushita K, Tonelli M, Lloyd A, Levey AS, Coresh J, Hemmelgarn BR, for the Alberta Kidney Disease Network. Clinical risk implications of the CKD Epidemiology Collaboration (CKD-EPI) equation compared with the Modification of Diet in Renal Disease (MDRD) study equation for estimated GFR. Am J Kidney Dis 2012;60:241-9.
-
(2012)
Am J Kidney Dis
, vol.60
, pp. 241-249
-
-
Matsushita, K.1
Tonelli, M.2
Lloyd, A.3
Levey, A.S.4
Coresh, J.5
Hemmelgarn, B.R.6
-
11
-
-
84902826499
-
Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality
-
published online 3 June
-
Coresh J, Turin TC, Matsushita K, Sang Y, Ballew SH, Appel LJ, et al. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 2014; published online 3 June.
-
(2014)
JAMA
-
-
Coresh, J.1
Turin, T.C.2
Matsushita, K.3
Sang, Y.4
Ballew, S.H.5
Appel, L.J.6
-
12
-
-
84862776975
-
Longitudinal progression trajectory of GFR among patients with CKD
-
Li L, Astor BC, Lewis J, Hu B, Appel LJ, Lipkowitz MS, et al. Longitudinal progression trajectory of GFR among patients with CKD. Am J Kidney Dis 2012;59:504-12.
-
(2012)
Am J Kidney Dis
, vol.59
, pp. 504-512
-
-
Li, L.1
Astor, B.C.2
Lewis, J.3
Hu, B.4
Appel, L.J.5
Lipkowitz, M.S.6
-
13
-
-
84862777509
-
Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis
-
O'Hare AM, Batten A, Burrows NR, Pavkov ME, Taylor L, Gupta I, et al. Trajectories of kidney function decline in the 2 years before initiation of long-term dialysis. Am J Kidney Dis 2012;59:513-22.
-
(2012)
Am J Kidney Dis
, vol.59
, pp. 513-522
-
-
O'Hare, A.M.1
Batten, A.2
Burrows, N.R.3
Pavkov, M.E.4
Taylor, L.5
Gupta, I.6
|